Abstract
In a world of neoadjuvant chemotherapy, which response is the more reliable indicator for prognosis in pancreatic ductal adenocarcinoma, radiologic or biochemical?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have